{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:01Z","timestamp":1767135181279,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012564","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000}}],"reference-count":64,"publisher":"Wiley","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012564.pub2","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T07:31:06Z","timestamp":1500967866000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Opioids for cancer-related pain in children and adolescents"],"prefix":"10.1002","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[{"name":"Thame UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tess E","family":"Cooper","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Karenia","family":"Anderson","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital; Department of Paediatric Oncology; Sutton UK SM2 5PT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L","family":"Gray","sequence":"additional","affiliation":[{"name":"University of Kwazulu-Natal; Division of Pharmacology, Discipline of Pharmaceutical Sciences; Private Bag 7 Congella KwaZulu-Natal South Africa 4013"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"IWK Health Centre, Dalhousie University; Paediatric Palliative Care, Department of Paediatrics; Halifax Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustaf","family":"Ljungman","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Uppsala University; Paediatric Oncology; Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Zernikow","sequence":"additional","affiliation":[{"name":"Children's and Adolescent's Hospital; German Paediatric Pain Centre; Datteln Germany"},{"name":"Witten\/Herdecke University, Faculty of Health, School of Medicine; Children's Pain Therapy and Paediatric Palliative Care; Datteln Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD012564.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5055\/jom.2015.0291","article-title":"Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone birtartrate","volume":"11","author":"Argoff","year":"2015","journal-title":"Journal of Opioid Management"},{"issue":"3","key":"10.1002\/14651858.CD012564.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3476(99)70457-9","article-title":"Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates","volume":"134","author":"Collins","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD012564.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jpain.2007.02.429","article-title":"Ketamine as an adjuvant for treatment of cancer pain in children and adolescents","volume":"8","author":"Finkel","year":"2007","journal-title":"Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD012564.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12098-010-0053-x","article-title":"Management of pain in leukemic children using the WHO analgesic ladder","volume":"77","author":"Geeta","year":"2009","journal-title":"Indian Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012564.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2003.10.006","article-title":"Use of strong opioids in advanced cancer pain: a randomized trial","volume":"27","author":"Marinangeli","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0006|cit6","unstructured":"American Cancer Society Cancer in children www.cancer.org\/cancer\/cancerinchildren\/detailedguide\/cancer-in-children-types-of-childhood-cancers (accessed July 2016)"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0007|cit7","unstructured":"American Medical Association Pediatric pain management https:\/\/www.ama-assn.org\/"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0008|cit8","unstructured":"Cochrane Pain Palliative and Supportive Care Group PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/j.pain.0000000000000403","article-title":"A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010","volume":"157","author":"Caes","year":"2016","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD012564.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012538.pub2","article-title":"Opioids for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012564.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012535.pub2","article-title":"Antidepressants for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012564.pub2-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012563.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012564.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012539.pub2","article-title":"Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"15","key":"10.1002\/14651858.CD012564.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain - United States","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"7404","key":"10.1002\/14651858.CD012564.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/bmj.326.7404.1408","article-title":"Management of chronic pain in children and adolescents. We need to address the embarrassing lack of data for this common problem","volume":"326","author":"Eccleston","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD012564.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012537.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents","author":"Eccleston","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9365","key":"10.1002\/14651858.CD012564.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(03)13038-3","article-title":"15 million new cancer cases per year by 2020, says WHO","volume":"361","author":"Frankish","year":"2003","journal-title":"Lancet"},{"issue":"7650","key":"10.1002\/14651858.CD012564.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012564.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE Guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"Making an overall rating of the confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0023|cit23","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0025|cit25","unstructured":"International Association on the Research of Cancer Global cancer facts & figures www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-027766.pdf"},{"issue":"4","key":"10.1002\/14651858.CD012564.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/ctrv.2010.02.003","article-title":"Epidemiology of childhood cancer","volume":"36","author":"Kaatsch","year":"2010","journal-title":"Cancer Treatment Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"2-3","key":"10.1002\/14651858.CD012564.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0304-3959(96)03193-4","article-title":"Treatment of pain in paediatric oncology: a Swedish nationwide survey","volume":"68","author":"Ljungman","year":"1996","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0029|cit29","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"7","key":"10.1002\/14651858.CD012564.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0031|cit31","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012564.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012564.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012564.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.2013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012564.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012564.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012564.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012564.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012564.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD012564.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0046|cit46","unstructured":"Twycross R Wilcock A Howard P Palliative care formulary Palliativedrugs.com (accessed September 2016)"},{"issue":"9","key":"10.1002\/14651858.CD012564.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpain.2008.04.007","article-title":"Core outcome domains and measures for pediatric acute and chronic\/recurrent pain clinical trials: PedIMMPACT","volume":"9","author":"McGrath","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0048|cit48","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2008.12.005","article-title":"Pain therapy","volume":"70","author":"Ripamonti","year":"2008","journal-title":"Journal of Hematology & Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012564.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD012564.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pain.2006.05.006","article-title":"Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents","volume":"125","author":"Stinson","year":"2006","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012564.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1002\/14651858.CD012564.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0189-6725.48567","article-title":"Paediatric solid tumours in Nigerian children: a changing pattern","volume":"6","author":"Tanko","year":"2009","journal-title":"African Journal of Paediatric Surgery"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0056|cit56","unstructured":"United Nations World population prospects 2017 - population indicators esa.un.org\/unpd\/wpp\/Download\/Standard\/Population"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/JPR.S4554","article-title":"Acute pain management in children","volume":"3","author":"Verghese","year":"2010","journal-title":"Journal of Pain Research"},{"issue":"1-2","key":"10.1002\/14651858.CD012564.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pain.2006.08.014","article-title":"Systematic review of observational (behavioural) measures of pain for children and adolescents aged 3 to 18 years","volume":"127","author":"Bayer","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0059|cit59","unstructured":"World Health Organization Cancer pain relief and palliative care in children apps.who.int\/iris\/bitstream\/10665\/42001\/1\/9241545127.pdf"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0060|cit60","unstructured":"World Health Organization Cancer Fact Sheet N\u00b0297 www.who.int\/mediacentre\/factsheets\/fs297\/en\/"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0061|cit61","unstructured":"World Health Organization WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses apps.who.int\/iris\/bitstream\/10665\/44540\/1\/9789241548120_Guidelines.pdf"},{"issue":"8","key":"10.1002\/14651858.CD012564.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012536.pub2","article-title":"Antiepileptic drugs for chronic non-cancer pain in children and adolescents","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012564.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012592","article-title":"Opioids for cancer pain - an overview of Cochrane reviews","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012564.pub2-BIB0064|cit64","unstructured":"The World Bank Data - population ages 0-14 (% of total) data.worldbank.org\/indicator\/SP.POP.0014.TO.ZS"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012564.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:08:18Z","timestamp":1628536098000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012564.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012564.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}